Thirty companies went public in the US in the third quarter of 2026 and raised a combined $32.8 billion, according to IPO research firm Renaissance Capital [1]. One deal, the US listing of South Korean memory-chip maker SK hynix, raised $26.5 billion, about 80% of the total; without it, proceeds were $6.2 billion [1]. The quarter's IPOs averaged a roughly flat return through September 30, and the Renaissance IPO Index fell 11.5%, as rising bond yields and a Fed rate hike cut short the usual fall pickup [1].
How busy was the IPO market in Q3 2026?
| Quarter | Number of IPOs | Proceeds | Median deal size | Average return |
|---|---|---|---|---|
| Q3 2025 | 64 | $15.3 billion | $16 million | +25.7% |
| Q4 2025 | 41 | $13.2 billion | $30 million | +13.3% |
| Q1 2026 | 34 | $9.9 billion | $226 million | +27.9% |
| Q2 2026 | 48 | $104.8 billion | $320 million | +10.8% |
| Q3 2026 | 30 | $32.8 billion | $211 million | -0.1% |
Source: Renaissance Capital, US IPO Market 3Q 2026 Quarterly Review; IPOs and direct listings with a market value of at least $50 million, excluding SPACs and closed-end funds; returns from offer price to the end of each quarter [1].
The second quarter's $104.8 billion included the record SpaceX listing in June, which DataPorium covered at the time [1][5]. The third quarter's 30 IPOs compared with a 10-year third-quarter average of 49 IPOs raising $12.1 billion [1]. Eighteen companies raised $100 million or more [1]. Deal flow was steady in July, paused in mid-August, and failed to pick up in September "as pressure from AI spending concerns, rising inflation, and a rate hike weighed on new issuance," the report said, ending with a string of postponements, including a delay by SB Energy [1].
What were the largest IPOs of Q3 2026?
| Company | Ticker | IPO date | Raised | First-day change | Return to Sep 30 |
|---|---|---|---|---|---|
| SK hynix | SKHY | Jul 9 | $26.5 billion | +12.8% | +23.6% |
| Csquare | CSQR | Jul 15 | $1.05 billion | -1.6% | -24.7% |
| Jersey Mike's Subs | JMKE | Jul 29 | $1.0 billion | -6.0% | -26.9% |
| Accelevation Holdings | ACCV | Sep 29 | $540 million | -0.3% | -0.3% |
| ADARx Pharmaceuticals | ADRX | Sep 24 | $446 million | +13.8% | +17.3% |
| Braveheart Bio | BRVE | Aug 5 | $383 million | +65.6% | +12.2% |
| Electra Therapeutics | ETRA | Sep 17 | $350 million | -11.7% | -25.0% |
| Latigo Biotherapeutics | LTGO | Aug 6 | $346 million | +1.4% | -7.2% |
Source: Renaissance Capital, returns as of September 30, 2026 [1].
SK hynix, one of the world's largest makers of memory chips used in AI servers, cross-listed in New York from Seoul. Its $26.5 billion offering was the largest US listing since SpaceX; the shares rose 13% on the first day and ended the quarter up 24% from the offer price [1]. DataPorium data show SKHY closed at $169.03 on October 9, 2026 [2].
Other large deals struggled. Data center operator Csquare priced below its expected range and ended the quarter 25% below its offer price, and the sandwich chain Jersey Mike's was down 27% [1]. Of all the quarter's IPOs, 30% priced below their expected range, the highest share in recent periods [1].
Which sectors went public, and which IPOs did best?
Health care led by number: nine biotech companies went public and raised $2.4 billion, and the sector's IPOs averaged a 16.6% return [1]. Technology raised the most money, $27.6 billion from three traditional IPOs, plus five direct listings [1]. Consumer companies returned to the market with Jersey Mike's and the clothing brand Reformation, and three financial companies listed, including two banks [1].
The best performers were mostly biotechs. Vogenx, which develops metabolic disease drugs, was up 75.3% from its offer price at the end of September, followed by IMC Rare Earths (+40.0%) and Apnimed (+36.9%), which is developing a pill for obstructive sleep apnea [1]. The worst were in out-of-favor themes: defense technology company Lyntris was down 29.5% and nuclear fuel maker Standard Nuclear 21.3% [1].
Private equity firms brought seven companies public, raising $29.7 billion, or $3.2 billion excluding SK hynix, and those traditional IPOs averaged a -9% return from offer [1]. Venture capital backed nine IPOs that raised $2.4 billion; eight of the nine were biotechs, and the group averaged a 6% return [1]. Traditional technology "unicorns", private startups valued at $1 billion or more, stayed on the sidelines again, the report said [1].
Direct listings, where a company lists existing shares without raising new money, had their busiest quarter ever with seven, but all but one ended the quarter below their opening price [1]. Blank-check companies (SPACs) raised $6.1 billion in 35 IPOs, down sharply from the first half [1].
Why did the fall IPO season stall?
Renaissance Capital named three reasons: concerns about AI spending, "a 19-year high in bond yields," and the Fed's return to rate hikes [1]. DataPorium data show the 10-year Treasury yield rose from 4.44% on June 30 to 5.29% on September 30, and the Fed raised its target range to 3.75% to 4.00% on September 16 [4]. Higher yields lower the value investors put on future profits, which hurts newly listed growth companies most. The Renaissance IPO Index fell 11.5% in the quarter while the S&P 500 returned 2.3%, though the IPO index still led the broader market for the year [1].
What is in the IPO pipeline for late 2026?
The biggest name in the pipeline is Anthropic, the AI company, which Renaissance Capital said "is currently expected to headline the 4Q26" [1]. OpenAI is "now waiting until 2027 to list," the report said [1]. Reporting cited by CNBC on September 30 said Anthropic was likely to wait until after the November midterm elections [6]. Among companies that have filed, SoftBank-backed SB Energy, which develops power generation for AI and data center customers, filed for an estimated $5 billion IPO before delaying it [1]. DataPorium's markets calendar tracks scheduled IPOs [3].
Thirty US IPOs raised $32.8 billion in Q3 2026, but $26.5 billion came from SK hynix, and the quarter's deals averaged a flat return as yields and a Fed hike weighed on new issues.
Frequently asked questions
What was the largest IPO in Q3 2026?
SK hynix's $26.5 billion US offering on July 9, 2026, the largest US listing since SpaceX, according to Renaissance Capital [1].
How many IPOs were there in Q3 2026?
Thirty, raising $32.8 billion, compared with 48 IPOs raising $104.8 billion in Q2 2026 [1].
When is the Anthropic IPO?
No date had been set as of October 1, 2026. Renaissance Capital said Anthropic was expected to headline fourth-quarter IPO activity, and CNBC reported on September 30 that it was likely to wait until after the November midterm elections [1][6].
Which Q3 2026 IPOs performed best?
Vogenx (+75.3%), IMC Rare Earths (+40.0%) and Apnimed (+36.9%) had the highest returns from their offer prices as of September 30, 2026 [1].
Sources & References
- [1] Renaissance Capital, US IPO Market 3Q 2026 Quarterly Review (October 1, 2026)
- [2] DataPorium SK hynix (SKHY) stock page (prices)
- [3] DataPorium Markets Calendar (IPO calendar)
- [4] DataPorium Interest Rates (Treasury yields and Fed decisions)
- [5] DataPorium article, How the SpaceX IPO was priced: first-day return, valuation and trading since June
- [6] CNBC, S&P 500 falls Wednesday despite softer-than-expected inflation data (September 30, 2026)
